Dr. Venkata Rami Reddy Emani, MD

Dr. Emani practices at Stockton Endoscopy Center in Stockton, California.

Dr. Emani's NPI, 1184706343, was assigned on October 19, 2006. Dr. Emani graduated from Andhra Medical College NTR in 1990. Dr. Emani holds California license A80313.

Dr. Emani's primary practice is Stockton Endoscopy Center, at 415 E Harding Way, Stockton, CA 95204 in San Joaquin County. The practice phone is (209) 942-1179.

Dr. Emani's primary practice is Stockton Endoscopy Center in Stockton, California. Dr. Emani is also affiliated with Dignity Health - St. Joseph's Medical Center. The medical group on file is Stockton Cardiology Medical Group. Dmand AI also links Dr. Emani to 4 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Emani practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Emani's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Emani is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Emani's licenses on file in 7 states: California, Texas, Illinois, Ohio, Kentucky, Virginia and Alabama.

Dmand AI lists angioplasty, cardiac catheterization and pacemaker or defibrillator implantation among the conditions Dr. Emani treats.

CMS data shows 9,072 Medicare services from Dr. Emani across 34 procedure codes in 2024, for 1,083 Medicare patients. Medicare paid $846,649 for them.

CMS counts 1,083 Medicare patients who saw Dr. Emani in 2024. The largest group is 65 to 74, with 414 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Emani's median patient age at 71, with 53% women.

In 2024, Dr. Emani wrote 9,728 Medicare Part D claims for 1,287 patients. 87% of them were for generic drugs. CMS names the drug for 9,393 of them, across 61 drugs with 11 or more claims each, at $1,434,824 in total drug cost. In 2023, CMS named 7,430 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Emani for performance year 2024, reported as part of a group. Dr. Emani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Emani as offering telehealth. CMS counts 11 procedures of pacemaker insertion or repair by Dr. Emani, more than 62% of the clinicians it reports for that procedure.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Emani, published from 2020 to 2022. 2022 was the busiest year, with 2. The most frequent topics are COVID-19, Antigens, CD and Disease Outbreaks. Dr. Emani has published most often in Transplant Proc. Dr. Emani's most frequent co-authors are Sanjeev Kumar Goswami, MD, Dheeraj Nandanoor, MD and Nikhila Reddy, MD.

Dmand AI links Dr. Emani to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carotid Stenosis and Carotid Artery Diseases.

CMS Open Payments shows 509 general payments to Dr. Emani from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,495.

Dr. Emani graduated from Andhra Medical College NTR in 1990.

Dr. Emani is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.